This new edition is an invaluable resource for specialists and trainees in pain management, containing up-to-date content on the assessment and managment of cancer-related breakthrough pain.
This new edition is an invaluable resource for specialists and trainees in pain management, containing up-to-date content on the assessment and managment of cancer-related breakthrough pain.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr Andrew Davies is a Consultant in Palliative Medicine from the United Kingdom. He has a long-standing clinical / research interest in breakthrough cancer pain (BTcP). He was the chair of the working group that produced the APM recommendations on BTcP, contributed to the EONS guidelines on BTcP, and has written numerous peer reviewed journal articles on the subject. He is current President of the APM, and is President-Elect of the MASCC.
Inhaltsangabe
1: Introduction 2: Clinical features 3: Assessment 4: General principles of management 5: Oral and parenteral opioids 6: Oral transmucosal opioids 7: Intranasal and intrapulmonary opioids 8: Non-opioid analgesics 9: Other therapeutic interventions
